VIRGINIJA BERNOTIENE: Open Payments
NPI 1659018547 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 50 payments from 18 companies in 2025. Trend: 2023 $1,922 · 2024 $2,148 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $393 |
| Regeneron Healthcare Solutions, Inc. | 5 | $313 |
| Amgen Inc. | 3 | $175 |
| Arcutis Biotherapeutics, Inc. | 7 | $175 |
| LEO Pharma Inc. | 2 | $146 |
| Lilly USA, LLC | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
| Botanix SB Inc | 2 | $34 |
| Incyte Corporation | 1 | $29 |
Products named: DUPIXENT, RINVOQ, OTEZLA, Zoryve, SKYRIZI, ANZUPGO, TALTZ, ILUMYA.
Industry payments across FL — which companies pay providers there.
